Freakonomics Radio
It may just be being human. Stephen Dubner interviews A.I. performer Tilly Norwood to find out if we are as replaceable as we fear. (Part two of a two-part series.)
- SOURCES:
- Sean Astin, actor, president of SAG-AFTRA.
- Kevin Kelly, co-founder of Wired.
- Ethan Mollick, associate professor of management at the Wharton School of the University of Pennsylvania.
- Tilly Norwood, A.I. performer.
- Eline Van der Velden, founder and C.E.O. of Particle6.
- Joel Waldfogel, economist at the University of Minnesota.
- RESOURCES:
- “Quiet, My Exoself,” by Kevin Kelly (KK, 2026).
- “How Large Language Models Are Reshaping the Book Market,” by Imke Reimers and Joel Waldfogel (NBER, 2026).
- “Intellectual Property and Creative Machines,” by Gaétan De Rassenfosse, Adam B. Jaffe, and Joel Waldfogel (NBER, 2024).
- Digital Renaissance: What Data and Economics Tell Us About the Future of Popular Culture, by Joel Waldfogel (2018).
- “The Random Long Tail and the Golden Age of Television,” by Joel Waldfogel (Innovation Policy and the Economy, 2017).
- “Quality Predictability and the Welfare Benefits From New Products: Evidence From the Digitization of Recorded Music,” by Luis Aguiar and Joel Waldfogel (NBER, 2016).
- “Copyright Protection, Technological Change, and the Quality of New Products: Evidence from Recorded Music since Napster,” by Joel Waldfogel (NBER, 2011).
- EXTRAS:
- “How to Survive the A.I. Shock,” by Freakonomics Radio (2026).
- “Should A.I. Move to Space?,” by Freakonomics Radio (2026).
- “Are Thousands of Medical Cures Hiding in Plain Sight?,” by Freakonomics Radio (2026).
- “Can A.I. Save Your Life?,” by Freakonomics Radio (2026).
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
-
459. Let’s Be Blunt: Marijuana Is a Boon for Older Workers
The state-by-state rollout of legalized weed has given economists a perfect natural experiment to measure its effects. Here’s what we know so far — and don’t know — about the costs and benefits of legalization.
-
459. Let’s Be Blunt: Marijuana Is a Boon for Older Workers
The state-by-state rollout of legalized weed has given economists a perfect natural experiment to measure its effects. Here’s what we know so far — and don’t know — about the costs and benefits of legalization.…
-
458. How to Manage Your Goal Hierarchy
In this special crossover episode, People I (Mostly) Admire host Steve Levitt admits to No Stupid Questions co-host Angela Duckworth that he knows almost nothing about psychology. But once Angela gives Steve a quick tutorial…
-
458. How to Manage Your Goal Hierarchy
In this special crossover episode, People I (Mostly) Admire host Steve Levitt admits to No Stupid Questions co-host Angela Duckworth that he knows almost nothing about psychology. But once Angela gives Steve a quick tutorial…
-
457. Is Dialysis a Test Case of Medicare for All?
Kidney failure is such a catastrophic (and expensive) disease that Medicare covers treatment for anyone, regardless of age. Since Medicare reimbursement rates are fairly low, the dialysis industry had to find a way to tweak…
-
457. Is Dialysis a Test Case of Medicare for All?
Kidney failure is such a catastrophic (and expensive) disease that Medicare covers treatment for anyone, regardless of age. Since Medicare reimbursement rates are fairly low, the dialysis industry had to find a way to tweak…
-
456. How to Fix the Hot Mess of U.S. Healthcare
Medicine has evolved from a calling into an industry, adept at dispensing procedures and pills (and gigantic bills), but less good at actual health. Most reformers call for big, bold action. What happens if, instead,…
-
456. How to Fix the Hot Mess of U.S. Healthcare
Medicine has evolved from a calling into an industry, adept at dispensing procedures and pills (and gigantic bills), but less good at actual health. Most reformers call for big, bold action. What happens if, instead,…
-
456. How to Fix the Hot Mess of U.S. Healthcare
Medicine has evolved from a calling into an industry, adept at dispensing procedures and pills (and gigantic bills), but less good at actual health. Most reformers call for big, bold action. What happens if, instead,…
-
Policymaking Is Not a Science (Yet) (Ep. 405 Rebroadcast)
Why do so many promising solutions — in education, medicine, criminal justice, etc. — fail to scale up into great policy? And can a new breed of “implementation scientists” crack the code?